| Ranbaxy Laboratories (BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028) |
 |
437.45  -14.75 (-3.26%) |
| BSE : Jul 18, 16:01 |
|
| 436.90 -15.60 (-3.45%) |
| NSE : Jul 18, 15:59 |
|
| Open |
440.40 |
Vol |
2,341,713 |
| Prev. Close |
452.20 |
|
|
|
Intraday |
52 Week |
|
| Highs |
464.40 |
613.70 |
|
| Lows |
423.70 |
299.90 |
|
|
| Open |
467.70 |
Vol |
6,236,676 |
| Prev. Close |
452.50 |
|
|
|
Intraday |
52 Week |
|
| Highs |
467.70 |
660.00 |
|
| Lows |
423.60 |
297.05 |
|
|
|
BID |
OFFER |
| Price |
433.00 |
437.45 |
| Quantity |
801.00 |
1,884.00 |
|
|
BID |
OFFER |
| Price |
0.00 |
436.90 |
| Quantity |
0.00 |
15,943.00 |
|
| Mkt Cap |
16,323.61 |
| |
* P/E |
26.71 |
| |
Div |
170.00 |
| |
* EPS (TTM) |
16.38 |
| |
B/V: |
67.99 |
| Mkt Lot |
1.00 |
| |
FV |
5.00 |
| |
* EPS: As per stand alone adjusted profit after extra-ordinary items |
|
| Historic Prices & Returns of Ranbaxy Labs |
Compare Price Performance With Peers |
| Price |
1 week |
2 week |
1 month |
3 month |
6 month |
9 month |
1 year |
| BSE |
/ |
NSE |
| 531.45 |
514.00 |
598.20 |
498.95 |
386.65 |
421.85 |
346.85 |
| -17.69% |
-14.89% |
-26.87% |
-12.33% |
13.14% |
3.7% |
26.12% |
| 532.15 |
513.95 |
597.50 |
499.40 |
387.90 |
418.55 |
347.05 |
| -17.9% |
-14.99% |
-26.88% |
-12.52% |
12.63% |
4.38% |
25.89% |
|
Gain/Loss |
|
|
|
| This page Auto Refreshes every 5 minutes |
|
|
|
| |
|
|
|
|
|
| BSE/NSE Notices - Ranbaxy Labs |
| Ranbaxy Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 29, 2008, inter alia, to consid |
| |
| more... |
| |
|
|
|
| Financials of Ranbaxy Labs |
Quarterly |
Annual
|
| Income Statement |
(Mar '08) |
(Dec '07) |
| Net Sales |
987.29 |
4293.02 |
| Other Income |
87.68 |
551.13 |
| PBDIT |
100.28 |
965.72 |
| Net Profit |
103.42 |
617.72 |
|
|
|
| Balance Sheet |
| Total Share Capital |
186.54 |
| Net Worth |
2538.40 |
| Total Debt |
3503.03 |
| Net Block |
1469.52 |
| Investments |
3237.55 |
| Net Current Assets |
1006.93 |
| Total Assets |
6041.42 |
|
|
|
|
|
|
|
|
|
| Company Facts - Ranbaxy Labs |
|
|
|
| Registrars |
Alankit Assignment Ltd.
2E/8, Blazeflash House,
R T A Division, 1st Floor
Jhandewalan Extension,
|
| Tel : 51540060, 51540061, 51540062, 51540063 |
| Fax : 51540064 |
| Email : nahar@alankit.com |
Website :
|
|
|
|
|
|
| Management - Ranbaxy Labs |
| |
| Harpal Singh Non Executive Chairman |
| Vivek Bharat Ram Director |
| Gurcharan Das Director |
| Sunil Godhwani Director |
| P S Joshi Director |
| Nimesh N Kampani Director |
| V K Kaul Director |
| Vivek Mehra Director |
| Ravi Mehrotra Director |
| Shivinder Mohan Singh Director |
| Surendra Daulet-Singh Director |
| Brian W Tempest Non Executive Director |
| Malvinder Mohan Singh Managing Director & CEO |
| Atul Sobti Whole Time Director & COO |
| Ramesh L Adige Whole Time Director |
| |
|
|
Offline
